Per-protocol analyses for the primary and key secondary outcome after 24 months<sup>a</sup>. | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Occurrence of outcome events during follow-up.

Juan A. Rodriguez-Feo (50183)
Willem E. Hellings (50184)
Frans L. Moll (50185)
Jean-Paul P. M. De Vries (50186)
Ben J. van Middelaar (50187)
Ale Algra (50188)
Joost Sluijter (50189)
Evelyn Velema (50190)
Theo van der Broek (50191)
William C. Sessa (50192)
Dominique P. V. De Kleijn (50193)
Gerard Pasterkamp (50194)

February 2013

*<p>years of follow-up until occurrence of primary outcome event or end of follow-up period</p

Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness analysis.

Maylen Liseth Rojas-Botero (10388966)
Julián Alfredo Fernández-Niño (10389105)
Leonardo Arregocés-Castillo (16954445)
Andrés Palacios-Clavijo (16954448)
Mariana Pinto-Álvarez (16954451)
Fernando Ruiz-Gómez (16954454)

September 2023

Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness ...

Per-protocol analysis of clinical outcomes in medical and surgical arms at 12 months of follow-up.

Abimbola O. Famuyide (4594558)
Shannon K. Laughlin-Tommaso (4594570)
Sherif A. Shazly (4594582)
Kirsten Hall Long (4594573)
Daniel M. Breitkopf (4594579)
Amy L. Weaver (484313)
Michaela E. McGree (4594576)
Sherif A. El-Nashar (4594567)
Maureen A. Lemens (4594561)
Matthew R. Hopkins (4594564)

November 2017

<p>Per-protocol analysis of clinical outcomes in medical and surgical arms at 12 months of follow-up...

Results for the two primary outcomes per protocol and intention-to-treat analysis.

Sabrina Eggmann (5963945)
Martin L. Verra (5892158)
Gere Luder (5963948)
Jukka Takala (24249)
Stephan M. Jakob (307732)

November 2018

Results for the two primary outcomes per protocol and intention-to-treat analysis.</p

Primary and secondary outcome measures at baseline and three-month follow-up.

Taweewat Wiangkham (773494)
Joan Duda (773495)
M. Sayeed Haque (6686093)
Jonathan Price (3574760)
Alison Rushton (773498)

May 2019

Primary and secondary outcome measures at baseline and three-month follow-up.</p

Main analysis: Overview of compliance and persistence in the DMD groups over an observation period of 24 months.

Kerstin Hansen (775785)
Katrin Schüssel (775786)
Marita Kieble (775787)
Johanna Werning (240285)
Martin Schulz (775788)
Robert Friis (92864)
Dieter Pöhlau (775789)
Norbert Schmitz (286521)
Joachim Kugler (775790)

July 2015

<p>Main analysis: Overview of compliance and persistence in the DMD groups over an observation perio...

% differences in primary outcomes at 6 months (main analysis), 12, 24 and 48 months.

Nicola Magrini (646515)
Giulio Formoso (646516)
Oreste Capelli (646517)
Emilio Maestri (646518)
Francesco Nonino (646519)
Barbara Paltrinieri (646520)
Cinzia Del Giovane (453921)
Claudio Voci (646521)
Lucia Magnano (646522)
Lisa Daya (646523)
Anna Maria Marata (646524)

October 2014

<p>% differences in primary outcomes at 6 months (main analysis), 12, 24 and 48 months.</p

Secondary efficacy variables at months 3, 6, 12, 18, and 24 (per-protocol dataset).

Gabriele Pohlig (267149)
Sonja C. Bernhard (1807537)
Johannes Blum (141240)
Christian Burri (141244)
Alain Mpanya (267142)
Jean-Pierre Fina Lubaki (1807546)
Alfred Mpoo Mpoto (1807534)
Blaise Fungula Munungu (1807519)
Patrick Mangoni N’tombe (1807627)
Gratias Kambau Manesa Deo (1807630)
Pierre Nsele Mutantu (1807651)
Florent Mbo Kuikumbi (1807633)
Alain Fukinsia Mintwo (1807636)
Augustin Kayeye Munungi (1807645)
Amadeu Dala (1807642)
Stephen Macharia (1807624)
Constantin Miaka Mia Bilenge (1807513)
Victor Kande Betu Ku Mesu (1807510)
Jose Ramon Franco (1807639)
Ndinga Dieyi Dituvanga (1807648)
Richard R. Tidwell (148409)
Carol A. Olson (1807531)

February 2016

<p>Secondary efficacy variables at months 3, 6, 12, 18, and 24 (per-protocol dataset).</p

Outcomes at 12 months follow-up compared between the intervention and the control groups.

Anna Barker (3448526)
Peter Cameron (848182)
Leon Flicker (95283)
Glenn Arendts (84730)
Caroline Brand (3448523)
Christopher Etherton-Beer (398694)
Andrew Forbes (454446)
Terry Haines (3631453)
Anne-Marie Hill (415096)
Peter Hunter (222839)
Judy Lowthian (3566432)
Samuel R. Nyman (6733592)
Julie Redfern (3221304)
De Villiers Smit (6733595)
Nicholas Waldron (3500894)
Eileen Boyle (6733598)
Ellen MacDonald (6733601)
Darshini Ayton (4065070)
Renata Morello (3448529)
Keith Hill (4065067)

May 2019

Outcomes at 12 months follow-up compared between the intervention and the control groups.</p

Treatment outcomes at 6- and 12-months, intention-to-treat and as-treated [17] analyses (% (n/N)).

Naomi Lince-Deroche (700158)
Craig van Rensburg (3157011)
Jaqueline Roseleur (5848118)
Busola Sanusi (5848121)
Jane Phiri (827350)
Pam Michelow (289529)
Jennifer S. Smith (283828)
Cindy Firnhaber (387170)

October 2018

Treatment outcomes at 6- and 12-months, intention-to-treat and as-treated [17] analyses (% (n/N)).</...

Occurrence of outcome events during follow-up.

Juan A. Rodriguez-Feo (50183)
Willem E. Hellings (50184)
Frans L. Moll (50185)
Jean-Paul P. M. De Vries (50186)
Ben J. van Middelaar (50187)
Ale Algra (50188)
Joost Sluijter (50189)
Evelyn Velema (50190)
Theo van der Broek (50191)
William C. Sessa (50192)
Dominique P. V. De Kleijn (50193)
Gerard Pasterkamp (50194)

February 2013

*<p>years of follow-up until occurrence of primary outcome event or end of follow-up period</p

Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness analysis.

Maylen Liseth Rojas-Botero (10388966)
Julián Alfredo Fernández-Niño (10389105)
Leonardo Arregocés-Castillo (16954445)
Andrés Palacios-Clavijo (16954448)
Mariana Pinto-Álvarez (16954451)
Fernando Ruiz-Gómez (16954454)

September 2023

Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness ...

Per-protocol analysis of clinical outcomes in medical and surgical arms at 12 months of follow-up.

Abimbola O. Famuyide (4594558)
Shannon K. Laughlin-Tommaso (4594570)
Sherif A. Shazly (4594582)
Kirsten Hall Long (4594573)
Daniel M. Breitkopf (4594579)
Amy L. Weaver (484313)
Michaela E. McGree (4594576)
Sherif A. El-Nashar (4594567)
Maureen A. Lemens (4594561)
Matthew R. Hopkins (4594564)

November 2017

<p>Per-protocol analysis of clinical outcomes in medical and surgical arms at 12 months of follow-up...

Main analysis: Overview of compliance and persistence in the DMD groups over an observation period of 24 months.

Kerstin Hansen (775785)
Katrin Schüssel (775786)
Marita Kieble (775787)
Johanna Werning (240285)
Martin Schulz (775788)
Robert Friis (92864)
Dieter Pöhlau (775789)
Norbert Schmitz (286521)
Joachim Kugler (775790)

July 2015

<p>Main analysis: Overview of compliance and persistence in the DMD groups over an observation perio...

% differences in primary outcomes at 6 months (main analysis), 12, 24 and 48 months.

Nicola Magrini (646515)
Giulio Formoso (646516)
Oreste Capelli (646517)
Emilio Maestri (646518)
Francesco Nonino (646519)
Barbara Paltrinieri (646520)
Cinzia Del Giovane (453921)
Claudio Voci (646521)
Lucia Magnano (646522)
Lisa Daya (646523)
Anna Maria Marata (646524)

October 2014

<p>% differences in primary outcomes at 6 months (main analysis), 12, 24 and 48 months.</p

Secondary efficacy variables at months 3, 6, 12, 18, and 24 (per-protocol dataset).

Gabriele Pohlig (267149)
Sonja C. Bernhard (1807537)
Johannes Blum (141240)
Christian Burri (141244)
Alain Mpanya (267142)
Jean-Pierre Fina Lubaki (1807546)
Alfred Mpoo Mpoto (1807534)
Blaise Fungula Munungu (1807519)
Patrick Mangoni N’tombe (1807627)
Gratias Kambau Manesa Deo (1807630)
Pierre Nsele Mutantu (1807651)
Florent Mbo Kuikumbi (1807633)
Alain Fukinsia Mintwo (1807636)
Augustin Kayeye Munungi (1807645)
Amadeu Dala (1807642)
Stephen Macharia (1807624)
Constantin Miaka Mia Bilenge (1807513)
Victor Kande Betu Ku Mesu (1807510)
Jose Ramon Franco (1807639)
Ndinga Dieyi Dituvanga (1807648)
Richard R. Tidwell (148409)
Carol A. Olson (1807531)

February 2016

<p>Secondary efficacy variables at months 3, 6, 12, 18, and 24 (per-protocol dataset).</p

Outcomes at 12 months follow-up compared between the intervention and the control groups.

Anna Barker (3448526)
Peter Cameron (848182)
Leon Flicker (95283)
Glenn Arendts (84730)
Caroline Brand (3448523)
Christopher Etherton-Beer (398694)
Andrew Forbes (454446)
Terry Haines (3631453)
Anne-Marie Hill (415096)
Peter Hunter (222839)
Judy Lowthian (3566432)
Samuel R. Nyman (6733592)
Julie Redfern (3221304)
De Villiers Smit (6733595)
Nicholas Waldron (3500894)
Eileen Boyle (6733598)
Ellen MacDonald (6733601)
Darshini Ayton (4065070)
Renata Morello (3448529)
Keith Hill (4065067)

May 2019

Outcomes at 12 months follow-up compared between the intervention and the control groups.</p

Treatment outcomes at 6- and 12-months, intention-to-treat and as-treated [17] analyses (% (n/N)).

Naomi Lince-Deroche (700158)
Craig van Rensburg (3157011)
Jaqueline Roseleur (5848118)
Busola Sanusi (5848121)
Jane Phiri (827350)
Pam Michelow (289529)
Jennifer S. Smith (283828)
Cindy Firnhaber (387170)

October 2018

Treatment outcomes at 6- and 12-months, intention-to-treat and as-treated [17] analyses (% (n/N)).</...

Occurrence of outcome events during follow-up.

Juan A. Rodriguez-Feo (50183)
Willem E. Hellings (50184)
Frans L. Moll (50185)
Jean-Paul P. M. De Vries (50186)
Ben J. van Middelaar (50187)
Ale Algra (50188)
Joost Sluijter (50189)
Evelyn Velema (50190)
Theo van der Broek (50191)
William C. Sessa (50192)
Dominique P. V. De Kleijn (50193)
Gerard Pasterkamp (50194)

February 2013

*<p>years of follow-up until occurrence of primary outcome event or end of follow-up period</p

Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness analysis.

Maylen Liseth Rojas-Botero (10388966)
Julián Alfredo Fernández-Niño (10389105)
Leonardo Arregocés-Castillo (16954445)
Andrés Palacios-Clavijo (16954448)
Mariana Pinto-Álvarez (16954451)
Fernando Ruiz-Gómez (16954454)

September 2023

Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness ...